Research Article |
|
Corresponding author: Georgi V. Lazarov ( doctorlazarov30@gmail.com ) © 2025 Georgi V. Lazarov.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Lazarov GV (2025) Estradiol-to-testosterone ratio and erectile dysfunction in men aged 35-45. Folia Medica 67(4): e143525. https://doi.org/10.3897/folmed.67.e143525
|
Aim: This study investigated the relationship between erectile dysfunction and the estradiol-to-testosterone ratio in men aged 35 to 45.
Materials and methods: Screening procedures were designed to select eugonadal men between 35 and 45 years of age to evaluate the impact of the estradiol-to-testosterone ratio on the development of erectile dysfunction. Out of 1,521 patients examined in the andrology office for erectile dysfunction between January 2013 and December 2019, a total of 73 men were included for evaluation. Erectile dysfunction was evaluated using the International Index of Erectile Function (IIEF). Twenty age-matched men without erectile dysfunction were randomly selected to form the control group. We measured the total serum testosterone level three times, every 45 days, for three months, and measured estradiol once at the third blood collection.
Results: Among the patients with erectile dysfunction, we observed the estradiol-to-testosterone ratio values ranging from 0.0042 to 0.0110. These values were significantly higher than those of the control group (0.0015–0.0020) (p<0.001). There were significant differences in the questionnaire score between the patients and the control group (p<0.001). We did not observe fluctuations in the blood flow to the artery profunda of the penis bilaterally during color Doppler ultrasound.
Conclusion: Our study suggests that erectile dysfunction in men aged 35 to 45 years may be associated with an estradiol-to-testosterone ratio of 0.0041–0.0110. In the clinical examination of these patients, it is necessary to test for estradiol in addition to testosterone.
erectile dysfunction, estradiol/testosterone ratio, testosterone, young men
Erectile dysfunction (ED) and low sexual desire are multifactorial diseases that affect 5% to 10% of men under the age of 40.[
The aim of this study was to investigate the relationship between erectile dysfunction and the estradiol-to-testosterone (E2/T) ratio in men aged 35-45 years.
From January 2013 to December 2019, we selected 73 Bulgarian men aged 35-45 years with ED and varying body mass indexes (BMIs), with no congenital or acquired reproductive diseases, and no mental disorders from a total of 1521 patients examined in the andrological office of St Sofia Hospital in Obstetrics and Gynecology. Twenty clinically healthy age-matched men with a normal BMI and without ED who visited the andrology office for a preventive examination served as our control group.
The analysis of patient data was performed by extracting data from our electronic database.
All patients gave written informed consent for the use of their data for scientific evaluation, in accordance with the Declaration of Helsinki for studies involving humans. The protocol was approved by the Ethics Committee of the Hospital (IC code: No. 3 / 28.11.2022)
In our study, we used the short form of the International Index of Erectile Function (IIEF) questionnaire.[
We determined the BMI of all men.[
The E2/T ratio was calculated from the results obtained for TT and E2 for each sample taken separately for each patient.
Following the third blood collection for serum testosterone and estradiol levels, an ultrasound scan of the penis was performed using a Mindray NS2 device with a 7.5 MHz sector converter for surface organs in all men. The deep penile artery (DPA) could be found easily along the length of the corpus cavernosum. Due to the symmetry of the changes in the two arteries, we deemed it sufficient to measure only the right artery. Analysis of blood flow in the deep penile artery included peak systolic velocity (PSV), end diastolic velocity (EDV), and resistance index (RI).[
RI = PSV – EDV/PSV [
The age, BMI, serum TT level, E2, E2/T ratio, International Index of Erectile Function (IIEF) scores, diameter of the DPA, PSV, EDV, and RI values for all patients were entered into IBM SPSS Statistics (version 25). The data were analyzed using means and standard deviations, an independent samples t-test, and correlation analysis. A significance level of p≤0.05 was used.
According to clinical and laboratory results, the men we studied were divided into five groups based on BMI[
1. Group 1: healthy controls, men without ED, BMI 19.71–24.68, E2/T ratio 0.0015–0.0020 (n=20);
2. Group 2: men with ED, BMI 19.44–23.80, E2/T ratio 0.0041–0.0088 (n=18);
3. Group 3: men with ED, BMI 25.34–28.84, E2/T ratio 0.0042–0.0081 (n=27);
4. Group 4: men with ED, BMI 31.26–34.81, E2/T ratio 0.0055–0.0090 (n=16);
5. Group 5: men with ED, BMI 35.91–38.94, E2/T ratio 0.0061–0.0110 (n=12);
All parameters except IIEF scores (Table
IIEF scores: the average number of points with the standard deviation and range from the answers to the questionnaire
| Parameter | Mean ± SD 1 | Range | |
| IIEF score | |||
| Group 1 | 1.000±0.000 | 1–1 | |
| Group 2 | 9.389±1.975 | 7–13 | |
| Group 3 | 9.074±1.639 | 6–13 | |
| Group 4 | 10.250±1.571 | 8–13 | |
| Group 5 | 8.750±2.006 | 6–12 |
| IIEF score | BMI | E2/T | |
| IIEF score | 1,000 | ||
| BMI | 0.393** | 1,000 | |
| E2/T | 0.524** | 0.517** | 1,000 |
| Parameter | Mean ± SD¹ | Range |
| Diameter of DPA (cm) | ||
| Group 1 | 0.505±0.128 | 0.3–0.7 |
| Group 2 | 0.439±0.114 | 0.3–07 |
| Group 3 | 0.430±0.091 | 0.3–0.7 |
| Group 4 | 0.481±0.122 | 0.3–0.7 |
| Group 5 | 0.442±0.108 | 0.3–0.7 |
| PSV (cm/sec) | ||
| Group 1 | 47.114±6.953 | 37.56–59.43 |
| Group 2 | 44.941±6.299 | 36.44–58.63 |
| Group 3 | 45.679±6.838 | 37.58–58.35 |
| Group 4 | 44.510±12.059 | 27.81–51.67 |
| Group 5 | 45.434±10.158 | 27.61–56.61 |
| EDV (cm/sec) | ||
| Group 1 | 7.792±0.815 | 6.69–9.71 |
| Group 2 | 8.102±1.065 | 6.58–10.35 |
| Group 3 | 8.426±1.257 | 6.64–11.39 |
| Group 4 | 8.118±2.055 | 5.28–9.44 |
| Group 5 | 7.636±2.066 | 5.42–10.63 |
| RI | ||
| Group 1 | 0.832±0.022 | 0.79–0.88 |
| Group 2 | 0.820±0.008 | 0.80–0.84 |
| Group 3 | 0.816±0.009 | 0.80–0.83 |
| Group 4 | 0.823±0.023 | 0.80–0.84 |
| Group 5 | 0.823±0.017 | 0.80–0.85 |
Publications on this topic in the relevant literature have used both the testosterone-to-estradiol ratio (T/E2)[
At the start of the study, we selected men aged between 35 and 45 years old. Upon completion of the study, no cases of erectile dysfunction (ED) were found in men aged 35 or 36; ED was observed only in men aged 37 to 45. Most authors associate ED onset in this age group with below-normal serum testosterone levels.[
The positive correlation we found between BMI and E2/T (r=0.517, p<0.001) confirms the view of many other authors who have demonstrated the importance of increased BMI for higher E2/T ratios.[
For the appearance of reproductive disorders and lower urinary tract symptoms, as well as the increase in the volume of the prostate gland, the change of the E2/T ratio is relatively clearer, due to the presence of receptors for testosterone and estradiol in the organs of the male reproductive system.[
Most studies on the relationship between E2/T and erectile dysfunction have focused on men over 50 years of age with testosterone values below 300 ng/dL (10.4 nmol/L).[
The average diameter of the DPA and blood flow parameters in our study were close to those of Jung et al.[
1. The E2/T ratio values were only observed once, so we cannot say how ED would develop in the future. Based on our preliminary data, we can conclude that if these values remain above 0.041 for an extended period of time, ED will occur in this group of young men.
2. The number of patients included in this pilot study is relatively small, and we are considering expanding it.
Our findings suggest that erectile dysfunction in men aged 35 to 45 years may be associated with estradiol-to-testosterone ratio values ranging from 0.0041 to 0.0110, and that estradiol should be tested alongside testosterone during clinical examinations of these patients.
This research did not receive any specific grant.
The author declares he has no conflict of interest.
The data that support the findings of this study are available on request from the corresponding author. They are not publicly available due to legal restrictions on publishing personal patient data.
All patients gave written informed consent for the use of their data for scientific evaluation, in accordance with the Declaration of Helsinki for studies involving humans. The protocol was approved by the Ethics Committee of the Hospital (IC code: No. 3/28.11.2022).